ARDX Stock Analysis: Buy, Sell, or Hold?
ARDX - Ardelyx, Inc.
$6.05
0.21 (3.60%)
▲
5d:
+4.49%
30d:
-0.66%
90d:
+10.0%
BUY
HIGH Confidence
Analysis Updated: Jun 18, 2026 12:00 AM ET
Earnings: Aug 03, 2026
Smart Money Accumulation
None View Scanner →
Strength: 5.7/10
Get Alerted When ARDX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ARDX trading at deep discount. Market pricing in -17.6% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: ARDX trading at deep discount. Market pricing in -17.6% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$15.16
Based on 7.0% avg growth
INTRINSIC VALUE TODAY
$9.41
35.7% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 21.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ARDX is currently trading at $6.05, which is considered fair relative to its 30-day fair value range of $5.61 to $6.32. From a valuation perspective, the stock is trading at a discount (Forward PE: 11.8) compared to its historical average (21.0). Remarkably, the market is currently pricing in an annual earnings decline of 17.6% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ARDX is in a strong uptrend. The price is approaching resistance at $6.07. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.6% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $16.30 (+169.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ARDX is in a strong uptrend. The price is approaching resistance at $6.07. A breakout above this level would be a bullish signal, while rejection here could lead to consolidation. The stock is showing strong short-term momentum, up 3.6% recently.
Market Sentiment: The stock shows a mixed technical setup (45/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $16.30 (+169.4%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$5.61 -
$6.32
Company Quality Score
59/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
77.1%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (45/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+3.6%)
- BULLISH: Trading 169.4% below Wall St target ($16.30)
Trading Range Analysis
30-Day Trading Range
$5.61 -
$6.32
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$5.39
Resistance Level
$6.07
Current Trend
Strong Uptrend
Technical data as of
Jun 18, 2026
Fundamental Context
Forward P/E (Next Year Est.)
11.75
Wall Street Target
$16.30
(+169.4%)
Revenue Growth (YoY)
27.5%
Profit Margin
-13.6%
Valuation Discount vs History
-17.6% cheaper
PE vs Historical
11.8 vs 21.0
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-17.6%
(market-implied from PE analysis)
1-Year Target
$5.44
(-10%)
2-Year Target
$4.90
(-19%)
3-Year Target
$4.41
(-27%)
3-Yr Target (if PE normalizes)
(PE: 12→21)
$7.89
(+30%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 11.7 to 21.0
Stabilization Target:
$10.82
(+78.8%)
PE Expansion Potential:
+78.8%
Share & Embed Analysis
Last updated: June 19, 2026 2:36 AM ET
Data refreshes hourly during market hours. Next update: 3:36 AM
Data refreshes hourly during market hours. Next update: 3:36 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ARDX showing a specific setup today?
Insider Activity (6 Months)
1
Buys
10
Sells
Net
INSIDERS SELLING
Recent Transactions
Michael Raab
SELL
41666 shares
2026-03-16
David M Mott
BUY
333333 shares
2026-02-20
Susan Hohenleitner
SELL
2033 shares
2026-02-20
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
29 analysts |
$88 | 57 HOLD |
|
ALNY
Alnylam Pharmaceuticals … |
STRONG BUY
30 analysts |
$439 | 52 HOLD |
|
VRTX
Vertex Pharmaceuticals I… |
BUY
34 analysts |
$549 | 65 BUY |
|
CRSP
Crispr Therapeutics AG |
BUY
28 analysts |
$84 | 57 HOLD |
|
LEGN
Legend Biotech Corp |
STRONG BUY
22 analysts |
$58 | 45 HOLD |
Advanced ARDX Option Strategies
Professional options setups generated by AI based on today's ARDX price and gamma walls.
